Apart from well-established prognostic factors like tumor size, node involvement, grade, hormone receptor status, proliferation index, HER2-enrichment intrinsic subtype and use of anti-HER2 therapy (3), efforts were continuously made to identify reversible and modifiable variables to predict treatment efficacy and disease outcomes. Here, ERBB2 is linked to neoplasm.